273 related articles for article (PubMed ID: 26522706)
21. Block excision of tumors of the anterior uvea. Report on 68 consecutive patients.
Naumann GO; Rummelt V
Ophthalmology; 1996 Dec; 103(12):2017-27; discussion 2027-8. PubMed ID: 9003335
[TBL] [Abstract][Full Text] [Related]
22. Chemotherapy plus local treatment in the management of intraocular retinoblastoma.
Murphree AL; Villablanca JG; Deegan WF; Sato JK; Malogolowkin M; Fisher A; Parker R; Reed E; Gomer CJ
Arch Ophthalmol; 1996 Nov; 114(11):1348-56. PubMed ID: 8906025
[TBL] [Abstract][Full Text] [Related]
23. Plaque radiotherapy for large posterior uveal melanomas (> or =8-mm thick) in 354 consecutive patients.
Shields CL; Naseripour M; Cater J; Shields JA; Demirci H; Youseff A; Freire J
Ophthalmology; 2002 Oct; 109(10):1838-49. PubMed ID: 12359604
[TBL] [Abstract][Full Text] [Related]
24. Causes of chemoreduction failure in retinoblastoma and analysis of associated factors leading to eventual treatment with external beam radiotherapy and enucleation.
Gündüz K; Günalp I; Yalçindağ N; Unal E; Taçyildiz N; Erden E; Geyik PO
Ophthalmology; 2004 Oct; 111(10):1917-24. PubMed ID: 15465557
[TBL] [Abstract][Full Text] [Related]
25. Conservative treatment of diffuse infiltrating retinoblastoma: optical coherence tomography-assisted diagnosis and follow-up in three consecutive cases.
Stathopoulos C; Moulin A; Gaillard MC; Beck-Popovic M; Puccinelli F; Munier FL
Br J Ophthalmol; 2019 Jun; 103(6):826-830. PubMed ID: 30049803
[TBL] [Abstract][Full Text] [Related]
26. Clinical features predictive of high-risk retinoblastoma in 403 Asian Indian patients: a case-control study.
Kaliki S; Srinivasan V; Gupta A; Mishra DK; Naik MN
Ophthalmology; 2015 Jun; 122(6):1165-72. PubMed ID: 25841975
[TBL] [Abstract][Full Text] [Related]
27. Juvenile Xanthogranuloma Involving the Eye and Ocular Adnexa: Tumor Control, Visual Outcomes, and Globe Salvage in 30 Patients.
Samara WA; Khoo CT; Say EA; Saktanasate J; Eagle RC; Shields JA; Shields CL
Ophthalmology; 2015 Oct; 122(10):2130-8. PubMed ID: 26189188
[TBL] [Abstract][Full Text] [Related]
28. Custom-designed plaque radiotherapy for nonresectable iris melanoma in 38 patients: tumor control and ocular complications.
Shields CL; Naseripour M; Shields JA; Freire J; Cater J
Am J Ophthalmol; 2003 May; 135(5):648-56. PubMed ID: 12719072
[TBL] [Abstract][Full Text] [Related]
29. Iris melanoma: risk factors for metastasis in 169 consecutive patients.
Shields CL; Shields JA; Materin M; Gershenbaum E; Singh AD; Smith A
Ophthalmology; 2001 Jan; 108(1):172-8. PubMed ID: 11150284
[TBL] [Abstract][Full Text] [Related]
30. Globe conserving treatment of the only eye in bilateral retinoblastoma.
Lee V; Hungerford JL; Bunce C; Ahmed F; Kingston JE; Plowman PN
Br J Ophthalmol; 2003 Nov; 87(11):1374-80. PubMed ID: 14609838
[TBL] [Abstract][Full Text] [Related]
31. Factors associated with elevated intraocular pressure in eyes with iris melanoma.
Shields CL; Materin MA; Shields JA; Gershenbaum E; Singh AD; Smith A
Br J Ophthalmol; 2001 Jun; 85(6):666-9. PubMed ID: 11371484
[TBL] [Abstract][Full Text] [Related]
32. Plaque Radiotherapy for Medulloepithelioma in 6 Cases From a Single Center.
Ang SM; Dalvin LA; Emrich J; Komarnicky L; Shields JA; Shields CL
Asia Pac J Ophthalmol (Phila); 2019; 8(1):30-35. PubMed ID: 30375203
[TBL] [Abstract][Full Text] [Related]
33. Resection of intraocular tumors (partial lamellar sclerouvectomy) in the pediatric age group.
Ramasubramanian A; Shields CL; Kytasty C; Mahmood Z; Shah SU; Shields JA
Ophthalmology; 2012 Dec; 119(12):2507-13. PubMed ID: 22917889
[TBL] [Abstract][Full Text] [Related]
34. Minimal exposure (one or two cycles) of intra-arterial chemotherapy in the management of retinoblastoma.
Shields CL; Kaliki S; Shah SU; Bianciotto CG; Liu D; Jabbour P; Griffin GC; Shields JA
Ophthalmology; 2012 Jan; 119(1):188-92. PubMed ID: 21975042
[TBL] [Abstract][Full Text] [Related]
35. Iris melanoma management with iodine-125 plaque radiotherapy in 144 patients: impact of melanoma-related glaucoma on outcomes.
Shields CL; Shah SU; Bianciotto CG; Emrich J; Komarnicky L; Shields JA
Ophthalmology; 2013 Jan; 120(1):55-61. PubMed ID: 22980742
[TBL] [Abstract][Full Text] [Related]
36. Diffuse iris melanoma: a report of 25 cases.
Demirci H; Shields CL; Shields JA; Eagle RC; Honavar SG
Ophthalmology; 2002 Aug; 109(8):1553-60. PubMed ID: 12153810
[TBL] [Abstract][Full Text] [Related]
37. Combined chemoreduction and adjuvant treatment for intraocular retinoblastoma.
Shields CL; Shields JA; Needle M; de Potter P; Kheterpal S; Hamada A; Meadows AT
Ophthalmology; 1997 Dec; 104(12):2101-11. PubMed ID: 9400771
[TBL] [Abstract][Full Text] [Related]
38. Diffuse anterior retinoblastoma with undetectable retinal involvement.
Khetan V; Sudrik S; Singh S; Gopal L; Krishnakumar S
J Pediatr Ophthalmol Strabismus; 2011 Feb; 48 Online():e7-9. PubMed ID: 21323307
[TBL] [Abstract][Full Text] [Related]
39. Plaque radiotherapy in the management of scleral-invasive conjunctival squamous cell carcinoma: an analysis of 15 eyes.
Arepalli S; Kaliki S; Shields CL; Emrich J; Komarnicky L; Shields JA
JAMA Ophthalmol; 2014 Jun; 132(6):691-6. PubMed ID: 24557333
[TBL] [Abstract][Full Text] [Related]
40. Chemoreduction plus focal therapy for retinoblastoma: factors predictive of need for treatment with external beam radiotherapy or enucleation.
Shields CL; Honavar SG; Meadows AT; Shields JA; Demirci H; Singh A; Friedman DL; Naduvilath TJ
Am J Ophthalmol; 2002 May; 133(5):657-64. PubMed ID: 11992863
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
